Table 2 Correlations of mirRNAhsa-mir-3923 expression in patients with STAD tissue with clinicopathologic variables.

ClinicalCharacteristics	Variables	No. of patients	miRNA hsa-mir-3923 expression		X²	P-value
ClinicalCharacteristics	Variables	No. of patients	High No.	Low No.	X²	P-value
Age(years)	≤55	69	30	39	1.488	0.223
Age(years)	å 55	316	163	153
Gender	Female	145	69	76	0.602	0.438
Gender	Male	240	124	116
Clinical stage	Stage I/II	165	75	90	1.552	0.231
	Stage III/IV	198	103	95
	Unknown	22	15	7
Grade	G1/2	142	66	76	1.493	0.222
	G3/4	236	125	111
	Gx (Not include)	7	2	5
T stage	T1/2	99	43	56	1.957	0.162
	T3/4	277	143	134
	Tx (Not included)	9	7	2
M stage	M0	344	167	177	3.288	0.070
	M1	27	18	9
	Mx (Not included)	14	6	8
N stage	N0	116	50	66	2.614	0.106
	N1/2/3	255	133	122
	Nx (Not included)	14	10	4
Vital Status	Survival	248	114	134	4.829	0.028
Vital Status	Death	137	79	58
Survival Time	≤3 years	359	178	181	0.638	0.424
Survival Time	å 3 years	26	15	11
Race	White	245	118	127	0.598	0.439
	Asian	79	42	37
	Black	11	6	5
	Unknown	50	26	24

Quick links

Search